Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy [1] (multiple letters)

Cancer

Volumn 97, Issue 12, 2003, Pages 3125-3126

  Österborg, Anders ^a   Brandberg, Yvonne ^a   Glaspy, John ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; ERYTHROPOIESIS; FUNCTIONAL ASSESSMENT; HEMATOPOIESIS; HEMOGLOBIN DETERMINATION; HUMAN; INDIVIDUALIZATION; LETTER; MAJOR CLINICAL STUDY; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STATISTICAL SIGNIFICANCE; VERTIGO;

EID: 0038390511     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11430     Document Type: Letter

References (0)